Position in MDXG
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$603,689
-$111,757 QoQ
Shares Held
152,833
+44.6% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. MDXG ranks #60 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in MDXG
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $603,689 | 152,833 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $715,446 | 105,679 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $520,860 | 74,622 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $279,214 | 45,698 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $467,027 | 61,451 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $579,373 | 60,226 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $327,975 | 55,495 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $361,766 | 52,203 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $508,199 | 66,000 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $1,600,752 | 182,526 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $1,438,309 | 197,299 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $813,320 | 123,044 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $112,157 | 32,891 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $79,654 | 28,653 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $70,730 | 24,645 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $64,212 | 18,505 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $137,253 | 29,141 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $176,107 | 29,157 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $115,927 | 19,130 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $201,661 | 16,120 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||